HEPION PHARMACEUTICALS INC (HEPA)

US4268973025 - Common Stock

1.37  +0.08 (+6.2%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
45.26M43.62M30.40M20.15M7.77M
Research and Development
35.64M33.27M20.40M12.00M3.18M
Selling, General, and Administrative Expenses
9.62M10.35M10.01M8.15M4.59M
Operating Income
-45.26M-43.62M-30.40M-20.15M-7.77M
Interest Income/Expense
-9.47K-10.00K-2.32M-180.00K-180.00K
Other Income/Expense
-877.65K410.00KN/AN/AN/A
Non Recurring Items
-3.19M-1.87MN/AN/AN/A
Income Before Taxes
-49.34M-45.08M-32.72M-20.32M-7.95M
Income Tax
-409.02K-2.88M0.0030.00K-910.00K
Net Income
-48.93M-45.34M-32.72M-20.36M-12.48M
EBITDA
-45.19M-43.54M-30.31M-20.12M-7.74M
 
Per Share Data
EPS Diluted Total Ops
-12.32-11.90-9.31-42.41-124.80
Non GAAP EPS
-12.32-11.80N/A-2.53N/A
 
Statistics

All data in USD

Charts